Redefining ADC Payload Design Through Degrader Conjugates & Evolving Medicinal Chemistry Principles
- Gain a clear understanding of how degrader antibody conjugates introduce new opportunities and risks compared to classical cytotoxic payload approaches
- Learn how medicinal chemistry strategies are evolving beyond potency to optimize broader property space including DMPK and developability considerations
- Explore practical frameworks for evaluating emerging payload modalities and determining when ADC delivery adds value over small molecule approaches